The Italian National Centre for Rare Diseases: where research and public health translate into action.
作者信息
Taruscio Domenica, Agresta Linda, Amato Annalisa, Bernardo Giuseppe, Bernardo Luana, Braguti Francesca, Carbone Pietro, Carta Claudio, Ceccarini Marina, Censi Federica, Coppola Simona, Crialese Patrizia, De Santis Marta, Diemoz Stefano, Donati Carlo, Gainotti Sabina, Ferrari Gianluca, Floridia Giovanna, Frank Claudio, Frazzica Rosa Giuseppa, Gentile Amalia E, Granata Orietta, Kodra Yllka, Latrofa Manuela, Laricchiuta Paola, Magrelli Armando, Morciano Cristina, Polizzi Agata, Razeto Stefania, Salvatore Marco, Sanseverino Antonella, Savini Daniele, Torreri Paola, Tosto Fabrizio, Villani Flavia, Vincenti Giorgio, Vittozzi Luciano
机构信息
Italian National Centre for Rare Diseases, National Institute of Health, Rome, Italy.
出版信息
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s591-605. doi: 10.2450/2014.0040-14s.
Abstract
摘要
相似文献
1
The Italian National Centre for Rare Diseases: where research and public health translate into action.意大利国家罕见病研究中心：科研与公共卫生转化为实际行动之地。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s591-605. doi: 10.2450/2014.0040-14s.
2
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines.意大利政府在药品发现、开发和获取方面的政策。
Clin Ther. 2018 Nov;40(11):1931-1940. doi: 10.1016/j.clinthera.2018.09.015. Epub 2018 Oct 27.
3
[Contradictions of public health policies geared to rare disorders: the example of the Osteogenesis Imperfecta Treatment Program in the Brazilian Unified Health System (SUS)].[面向罕见病的公共卫生政策矛盾：以巴西统一卫生系统（SUS）中的成骨不全治疗项目为例]
Cien Saude Colet. 2014 Feb;19(2):475-80. doi: 10.1590/1413-81232014192.15582012.
4
[Rare diseases. Funding programs in Germany and Europe].[罕见病。德国和欧洲的资助项目]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 May;51(5):519-28. doi: 10.1007/s00103-008-0524-7.
5
A system to save lives in Italy: A cultural challenge for community and government.意大利的一个拯救生命的系统：对社区和政府的文化挑战。
Resuscitation. 2019 Sep;142:25-27. doi: 10.1016/j.resuscitation.2019.06.292. Epub 2019 Jul 11.
6
Addressing a potential crisis in the Italian National Health System.应对意大利国家卫生系统的潜在危机。
Lancet. 2023 Apr 15;401(10384):1262-1263. doi: 10.1016/S0140-6736(23)00450-6.
7
Putting E-government to work in healthcare environment: a multiregional project funded by the Italian Innovation & Technology Ministry.将电子政务应用于医疗环境：一个由意大利创新与技术部资助的多区域项目。
Stud Health Technol Inform. 2004;107(Pt 2):1173-7.
8
How does whole of government action address inequities in obesity? A case study from Australia.政府整体行动如何解决肥胖方面的不平等问题？来自澳大利亚的案例研究。
Int J Equity Health. 2019 Jan 14;18(1):8. doi: 10.1186/s12939-019-0913-6.
9
When the government actively faces the burden of osteoporosis: the Italian experience.当政府积极应对骨质疏松症负担时：意大利的经验。
Arch Osteoporos. 2012;7:21-4. doi: 10.1007/s11657-012-0077-0. Epub 2012 Jul 26.
10
Centralised versus decentralised funding of evaluative research: impact on medical technology policy in Italy.评估研究的集中式与分散式资金投入：对意大利医疗技术政策的影响
Soc Sci Med. 1994 Jun;38(12):1635-41. doi: 10.1016/0277-9536(94)90064-7.
引用本文的文献
1
The Italian institutional accreditation model for Haemophilia Centres.意大利血友病中心的机构认证模式。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s510-4. doi: 10.2450/2014.0058-14s.
2
Haemophilia Centre Certification Systems: optional or optimal choice for healthcare systems?血友病中心认证系统：医疗系统的可选还是最佳选择？
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s492-4. doi: 10.2450/2014.0076-14s.
本文引用的文献
1
Predictive medicine and biomarkers: the case of rare diseases.预测医学与生物标志物：罕见病案例
Per Med. 2012 Mar;9(2):143-146. doi: 10.2217/pme.12.17.
2
RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research.RD-Connect：一个连接数据库、登记处、生物样本库和临床生物信息学以进行罕见病研究的集成平台。
J Gen Intern Med. 2014 Aug;29 Suppl 3(Suppl 3):S780-7. doi: 10.1007/s11606-014-2908-8.
3
The Italian National Plan for Rare Diseases.意大利罕见病国家计划。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s614-6. doi: 10.2450/2014.0337-13s.
4
Current status of Italian Registries on inherited bleeding disorders.意大利遗传性出血性疾病登记处的现状。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s576-81. doi: 10.2450/2014.0017-14s.
5
A model for the European platform for rare disease registries.欧洲罕见病注册平台模型。
Public Health Genomics. 2013;16(6):299-304. doi: 10.1159/000355935. Epub 2014 Feb 3.
6
The current situation and needs of rare disease registries in Europe.欧洲罕见病登记处的现状与需求
Public Health Genomics. 2013;16(6):288-98. doi: 10.1159/000355934. Epub 2014 Feb 3.
7
EUROPLAN: a project to support the development of national plans on rare diseases in Europe.欧洲罕见病计划：一项支持欧洲各国制定罕见病计划的项目。
Public Health Genomics. 2013;16(6):278-87. doi: 10.1159/000355932. Epub 2014 Feb 3.
8
Developmental expression of dysbindin in Muller cells of rat retina.大鼠视网膜 Muller 细胞中 dysbindin 的发育表达。
Exp Eye Res. 2013 Nov;116:1-8. doi: 10.1016/j.exer.2013.08.006. Epub 2013 Aug 14.
9
Monocytes and macrophages as biomarkers for the diagnosis of megalencephalic leukoencephalopathy with subcortical cysts.单核细胞和巨噬细胞作为脑积水分流术相关巨脑白质脑病的生物标志物。
Mol Cell Neurosci. 2013 Sep;56:307-21. doi: 10.1016/j.mcn.2013.07.001. Epub 2013 Jul 10.
10
A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document.启动欧盟新生儿筛查政策辩论的框架：一份专家意见文件。
Eur J Hum Genet. 2014 Jan;22(1):12-7. doi: 10.1038/ejhg.2013.90. Epub 2013 May 8.
Zotero 插件